An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury
暂无分享,去创建一个
D. Harvey | C. DeCarli | J. Kramer | F. Elahi | P. Maillard | D. Elashoff | J. Hinman | Baljeet Singh | S. Sheth | M. Leng | S. Walters | A. Wolf | M. You | M. Altendahl | Guanxi Xiao | Visesha Kakarla | Ida Azizkhanian | E. Fox | Devyn L Cotter | Devyn L. Cotter | Michelle You | Samantha M. Walters | Amy Wolf
[1] A. Stępień,et al. IL-1α and IL-6 predict vascular events or death in patients with cerebral small vessel disease-Data from the SHEF-CSVD study. , 2019, Advances in medical sciences.
[2] Jackson T. Wright,et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. , 2019, JAMA.
[3] J. O'Brien,et al. Inflammation and cerebral small vessel disease: A systematic review , 2019, Ageing Research Reviews.
[4] Ninon Burgos,et al. New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .
[5] Richard Frayne,et al. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations , 2019, Alzheimer's & Dementia.
[6] C. Decarli,et al. Cerebral white matter free water , 2019, Neurology.
[7] J. Williamson,et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial , 2019, JAMA.
[8] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[9] A. Stępień,et al. Cerebral and Extracerebral Vasoreactivity in Patients With Different Clinical Manifestations of Cerebral Small‐Vessel Disease: Data From the Significance of Hemodynamic and Hemostatic Factors in the Course of Different Manifestations of Cerebral Small‐Vessel Disease Study , 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[10] W. Niessen,et al. Practical Small Vessel Disease Score Relates to Stroke, Dementia, and Death: The Rotterdam Study , 2018, Stroke.
[11] C. DeCarli,et al. “Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders , 2018, Front. Aging Neurosci..
[12] Wenli Hu,et al. Twenty-four-hour ambulatory blood pressure variability is associated with total magnetic resonance imaging burden of cerebral small-vessel disease , 2018, Clinical interventions in aging.
[13] Yaping Yan,et al. Emerging Role of Immunity in Cerebral Small Vessel Disease , 2018, Front. Immunol..
[14] G. Kaplanski. Interleukin‐18: Biological properties and role in disease pathogenesis , 2017, Immunological reviews.
[15] F. Spertini,et al. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease , 2017, Annals of the rheumatic diseases.
[16] C. Jack,et al. Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study , 2017, Stroke.
[17] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[18] Evan Fletcher,et al. Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity: A Continuum of Injury , 2017, Stroke.
[19] J. Wardlaw,et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.
[20] J. Kelsen,et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. , 2017, The Journal of allergy and clinical immunology.
[21] J. Staals,et al. Total Cerebral Small Vessel Disease MRI Score Is Associated with Cognitive Decline in Executive Function in Patients with Hypertension , 2016, Front. Aging Neurosci..
[22] David S Liebeskind,et al. Principles of precision medicine in stroke , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[23] J. Kramer,et al. MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes , 2016, Alzheimer's & dementia.
[24] O. Benavente,et al. Abstract WP160: Inflammatory Markers and Outcomes After Lacunar Stroke: the Levels of Inflammatory Markers in Treatment of Stroke Study , 2016, Stroke.
[25] C. DeCarli,et al. Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke , 2015, Stroke.
[26] S. Carmichael,et al. Molecular disorganization of axons adjacent to human lacunar infarcts. , 2015, Brain : a journal of neurology.
[27] P. Wolf,et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease , 2015, Neurology.
[28] Mark D. Johnson,et al. C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study , 2014, Stroke.
[29] C. Dinarello,et al. Interleukin-18 and IL-18 Binding Protein , 2013, Front. Immunol..
[30] Owen T. Carmichael,et al. Coevolution of brain structures in amnestic mild cognitive impairment , 2013, NeuroImage.
[31] A. Stępień,et al. Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study—Study Rationale and Protocol , 2013, Neuroscience journal.
[32] Evan Fletcher,et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study , 2012, The Lancet Neurology.
[33] Evan Fletcher,et al. Adaptive image segmentation for robust measurement of longitudinal brain tissue change , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[34] Robert J. van Oostenbrugge,et al. Vascular inflammation in cerebral small vessel disease , 2012, Neurobiology of Aging.
[35] K. Kitagawa,et al. Relations of Blood Inflammatory Marker Levels With Cerebral Microbleeds , 2011, Stroke.
[36] M. Woodward,et al. Interleukin 18 and coronary heart disease: Prospective study and systematic review , 2011, Atherosclerosis.
[37] C. DeCarli,et al. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). , 2011, Atherosclerosis.
[38] H. Markus,et al. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[39] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[40] C. Dinarello,et al. High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. , 2010, Journal of autoimmunity.
[41] B. Conti,et al. Interleukin 18 in the CNS , 2010, Journal of Neuroinflammation.
[42] J. P. de Rivero Vaccari,et al. Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] S. Rabkin. The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease , 2009, Nature Clinical Practice Cardiovascular Medicine.
[44] E. Air,et al. Clinical Prediction of Functional Outcome After Ischemic Stroke: The Surprising Importance of Periventricular White Matter Disease and Race , 2009, Stroke.
[45] P. Langhorne,et al. Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke , 2009, Cerebrovascular Diseases.
[46] J. Danesh,et al. Leptin and coronary heart disease: prospective study and systematic review. , 2009, Journal of the American College of Cardiology.
[47] C. Dinarello,et al. Interleukin-18 Binding Protein in the Sera of Patients with Wegener’s Granulomatosis , 2008, Journal of Clinical Immunology.
[48] C. Dinarello,et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.
[49] D. Harvey,et al. Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden , 2005, Stroke.
[50] Paul M. Ridker,et al. Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.
[51] J. Losy,et al. Interleukin-18 in acute ischaemic stroke patients , 2003, Neurological Sciences.
[52] F. Cambien,et al. Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina , 2002, Circulation.
[53] G. Stoll,et al. Interleukin-18 Expression after Focal Ischemia of the Rat Brain: Association with the Late-Stage Inflammatory Response , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[54] C. Jack,et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume , 2001, Journal of magnetic resonance imaging : JMRI.
[55] Natalia S. Rost,et al. Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.
[56] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[57] N. Rothwell,et al. Detection of the interleukin 18 family in rat brain by RT-PCR. , 2000, Brain research. Molecular brain research.
[58] M Eisenstein,et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[59] G. Fantuzzi,et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] N. Rothwell,et al. Cloning of rat brain interleukin-18 cDNA , 1998, Molecular Psychiatry.
[61] F. Fazekas,et al. Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.
[62] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.